"Second Opinion" with Christina Farr, Ash Zenooz MD, & Luba Greenwood JD
Second Opinion doesn't hold back. Join Christina Farr, Ash Zenooz, Luba Greenwood, as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. This season, we’re tackling meaty topics like biose...
Recent Episodes
April 16, 2025
The healthcare check-in: HES, tariffs, AI and more
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood discuss the latest trends in healthcare, including conferences, the economic impact on health tech and biotech sectors, the potential for AI to reduce administrative burdens, and the dynamics of the IPO market.
April 9, 2025
Dr. Jeff Wessler on longevity: heart attacks aren't random
In this episode, Christina Farr sits down with Dr. Jeff Wessler, cardiologist and CEO of Heartbeat Health, about the challenges of behavior change in cardiology, the role of technology in health, the importance of preventativ...
April 2, 2025
Why 25% of Gen Z might need a different type of healthcare, with Liana Guzmán CEO of FOLX
This week on Second Opinion, Christina Farr interviews Liana Guzman, CEO of FOLX, about the healthcare challenges faced by the LGBTQ+ community. They discuss systemic discrimination, the growing demand for inclusive care, and...
March 26, 2025
The fertility conversation we're not having (but should) with Carrot's Dr. Asima Ahmad
In this episode of Second Opinion, Christina Farr interviews Dr. Asima Ahmad MD, MPH, FACOG, Co-founder and Chief Medical Officer of Carrot, discussing her journey as a fertility specialist and entrepreneur.
March 19, 2025
Are there better alternatives to Ozempic with Sami Inkinen, CEO of Virta Health
This week on Second Opinion, we're featuring Christina Farr, Ash Zenooz, and Luba Greenwood's conversation with Sami Inkinen, CEO of Virta Health.
March 12, 2025
Why health care entrepreneurs need to be missionaries, not mercenaries — with angel investor Zen Chu
This week on Second Opinion, Christina Farr sits down with healthcare investing legend Zen Chu, who shares his framework for backing resilient entrepreneurs and insights from early investments in companies like Abridge and PillPack.
Join the Email List
Listen On
